VIDEO: Biosimilar Interchangeability and Market Share
by Ha Kung Wong
October 30, 2017
Watch Ha Kung Wong, Amanda Forys, and Molly Burich discuss the question, “Will biosimilar manufacturers seeking interchangeability have an effect on how reference product sponsors attempt to protect market share?” as part of the The Center for Biosimilars™ Peer Exchange®.
Ha Kung Wong
has extensive experience litigating a wide variety of pharmaceutical cases, including those concerning biologics used to treat rheumatoid arthritis and autoimmune disorders. He also has extensive experience consulting, conducting due diligence and licensing pharmaceutical portfolios. Ha Kung has a B.S. in Biochemistry and a B.S. in Chemistry.